Newsroom
-
July 16 , 2020
Pin-prick blood test used to test for radiation exposure in mice
- A team of researchers at The Ohio State University has developed a pin-prick-type blood test for measuring the amount of radiation exposure in mice. In their paper published in the journal Science Translational Medicine, the group describes building on previous work to develop the test, and how well it worked in lab mice.
Read more -
July 16 , 2020
AC Immune Stock Catapults To Two-Year High On Alzheimer's News
- Shares of AC Immune (ACIU) surged in massive volume Thursday after the small biotech company began dosing patients with an Alzheimer's treatment. The decision follows interim data from a prior clinical study. That earlier study showed the experimental Alzheimer's treatment was safe at a lower dose. Now, AC Immune is testing a higher dose of the drug. C
Read more -
July 15 , 2020
Infusion of certain immune cells may help in severe coronavirus cases
- An infusion of cells that dampen the body's immune response might help people with severe cases of the new coronavirus recover more quickly, a new report suggests.
Read more -
July 15 , 2020
Boosting immune memory could reduce cancer recurrence
- Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine. The research was published this week in Nature Immunology.
Read more -
July 15 , 2020
Immunotherapy with CAR T cells results in exceptional patient recovery
- In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells.
Read more -
July 15 , 2020
Sylvester researchers identify protein target that might ease graft versus host disease
- In a new study published in Science Translational Medicine, Robert Levy, Ph.D., along with graduate student and first author Cameron Bader and colleagues, have shown that inhibiting the STING protein pathway could protect certain patients from graft versus host disease, the most serious complication from bone marrow (stem cell) transplants.
Read more -
July 14 , 2020
First Coronavirus Vaccine Tested in Humans Shows Early Promise
- An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus and appeared safe in the first 45 people who received it, researchers reported on Tuesday in The New England Journal of Medicine.
Read more -
July 13 , 2020
Amgen Announces Additional Investment In BeiGene
- Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares
Read more -
July 13 , 2020
Cancer Stakeholders Call for Consensus of Terms to Encourage Patients’ Genetic Testing
Read more -
July 13 , 2020
Coronavirus vaccine update: Bharat Biotech starts human trials; Russia successfully completes human testing
- As global efforts are on to develop a safe and affordable COVID-19 vaccine, the big question remains unanswered: When will it be ready? India, which is only behind the United States and Brazil in coronavirus numbers, is also quickening up its pace to find a potent drug as early as possible. However, since the Centre is yet to announce a national policy on CO
Read more -
July 13 , 2020
Massachusetts biotech Revitope scores first collaboration thanks to dual-engaging T cell platform
- Revitope Oncology began 2020 hopeful that its cancer immunology platform would be finally ready to flourish. On Monday night, that platform nabbed the biotech its first collaboration.
Read more -
July 12 , 2020
Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders
- The Data Demonstrating Benefits of Pharmacokinetic-Guided Prophylaxis Therapy in Hemophilia and von Willebrand Disease are Among 13 Presentations from Takeda’s Hematology Portfolio and Pipeline
Read more